These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6893581)

  • 1. Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse.
    Meyer RA; Gray RW; Meyer MH
    Endocrinology; 1980 Nov; 107(5):1577-81. PubMed ID: 6893581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma 1,25-dihydroxyvitamin D after low calcium challenge in X-linked hypophosphatemic mice.
    Meyer RA; Gray RW; Roos BA; Kiebzak GM
    Endocrinology; 1982 Jul; 111(1):174-7. PubMed ID: 6896304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that low plasma 1,25-dihydroxyvitamin D causes intestinal malabsorption of calcium and phosphate in juvenile X-linked hypophosphatemic mice.
    Meyer RA; Meyer MH; Gray RW; Bruns ME
    J Bone Miner Res; 1987 Feb; 2(1):67-82. PubMed ID: 3455158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 25-hydroxyvitamin D3 in renal slices from the X-linked hypophosphatemic (Hyp) mouse: abnormal response to fall in serum calcium.
    Tenenhouse HS
    Cell Calcium; 1984 Feb; 5(1):43-55. PubMed ID: 6608994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal 24-hydroxylation of 25-hydroxyvitamin D in the X-linked hypophosphatemic mouse.
    Cunningham J; Gomes H; Seino Y; Chase LR
    Endocrinology; 1983 Feb; 112(2):633-8. PubMed ID: 6600222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable phosphate-mediated regulation of vitamin D metabolism in the murine hypophosphatemic rachitic/osteomalacic disorders.
    Davidai GA; Nesbitt T; Drezner MK
    Endocrinology; 1991 Mar; 128(3):1270-6. PubMed ID: 1999147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS; Jones G
    J Clin Invest; 1990 May; 85(5):1450-5. PubMed ID: 2332500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 24,25-dihydroxyvitamin D3 concentrations in X-linked hypophosphatemic mice: studies using mass fragmentographic and radioreceptor assays.
    Cunningham J; Coldwell RD; Jones G; Tenenhouse HS; Trafford DJ; Makin HL
    J Bone Miner Res; 1990 Feb; 5(2):173-7. PubMed ID: 2316405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1,25-dihydroxyvitamin D3 on phosphate homeostasis in the X-linked hypophosphatemic (Hyp) mouse.
    Tenenhouse HS; Scriver CR
    Endocrinology; 1981 Aug; 109(2):658-60. PubMed ID: 6894727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
    Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
    J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phosphate supplementation on the expression of the mutant phenotype in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS; Martel J; Rubin J; Harvey N
    Bone; 1994; 15(6):677-83. PubMed ID: 7873297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L
    J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE; Glorieux FH
    Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF
    Am J Dis Child; 1980 Feb; 134(2):140-3. PubMed ID: 6243443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased intestinal absorption of calcium in young and adult X-linked hypophosphatemic mice after the administration of 1,25-dihydroxyvitamin D3.
    Meyer MH; Meyer RA
    J Bone Miner Res; 1988 Apr; 3(2):151-7. PubMed ID: 3213610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a radioimmunoassay for mouse osteocalcin: paradoxical response in the Hyp mouse.
    Gundberg CM; Clough ME; Carpenter TO
    Endocrinology; 1992 Apr; 130(4):1909-15. PubMed ID: 1547718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
    Marie PJ; Travers R; Glorieux FH
    Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR; Baylink DJ; Jones PG; Haussler MR
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
    Scriver CR; Reade TM; DeLuca HF; Hamstra AJ
    N Engl J Med; 1978 Nov; 299(18):976-9. PubMed ID: 308618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS; Yip A; Jones G
    J Clin Invest; 1988 Feb; 81(2):461-5. PubMed ID: 3339128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.